Cdc123 Antibodies

Santa Cruz Biotechnology delivers a wide array of Cdc123 monoclonal antibodies for research focused on understanding cell cycle regulation. Cdc123 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cdc123 plays a vital role in cell cycle regulation and maintains genomic stability. Research has shown that Cdc123 is essential for proper cell division, and its dysregulation can contribute to various diseases, including cancer. Investigating Cdc123 function and regulation provides valuable insights into potential therapeutic targets. Understanding Cdc123's molecular mechanisms helps reveal new approaches for disease treatment. Ongoing studies of Cdc123 continue to uncover its significance in cellular processes. Current research explores how Cdc123 interacts with other proteins during cell division. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of cell cycle regulation and disease mechanisms.